These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 30229522)
1. Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis. Gámez B; Edwards CM Curr Osteoporos Rep; 2018 Dec; 16(6):635-641. PubMed ID: 30229522 [TBL] [Abstract][Full Text] [Related]
3. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity. Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394 [TBL] [Abstract][Full Text] [Related]
4. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study. Golombick T; Diamond TH; Manoharan A; Ramakrishna R Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes. Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS). Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309 [TBL] [Abstract][Full Text] [Related]
8. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma. Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149 [TBL] [Abstract][Full Text] [Related]
9. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma. Zingone A; Kuehl WM Semin Hematol; 2011 Jan; 48(1):4-12. PubMed ID: 21232653 [TBL] [Abstract][Full Text] [Related]
11. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS). Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315 [TBL] [Abstract][Full Text] [Related]
12. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma. Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492 [TBL] [Abstract][Full Text] [Related]
13. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma. Mailankody S; Mena E; Yuan CM; Balakumaran A; Kuehl WM; Landgren O Leuk Lymphoma; 2010 Dec; 51(12):2159-70. PubMed ID: 20958231 [TBL] [Abstract][Full Text] [Related]
14. A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance. Sandecká V; Hájek R; Pour L; Špička I; Ščudla V; Gregora E; Radocha J; Walterová L; Kessler P; Zahradová L; Adamová D; Valentova K; Vonke I; Obernauerová J; Starostka D; Wróbel M; Brožová L; Jarkovský J; Mikulášová A; Říhová L; Ševčíková S; Straub J; Minařík J; Adam Z; Krejčí M; Král Z; Maisnar V; Eur J Haematol; 2017 Jul; 99(1):80-90. PubMed ID: 28384387 [TBL] [Abstract][Full Text] [Related]
15. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study. Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance. Skrtić A; Korać P; Krišto DR; Ajduković Stojisavljević R; Ivanković D; Dominis M Hum Pathol; 2010 Dec; 41(12):1702-10. PubMed ID: 20800871 [TBL] [Abstract][Full Text] [Related]
17. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma]. Stelmach-Gołdyś A; Czarkowska-Paczek B Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415 [TBL] [Abstract][Full Text] [Related]